Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heat Biologics, Inc. - Common Stock (NY: HTBX )

N/A UNCHANGED
Last Price Updated: 8:00 PM EDT, May 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heat Biologics, Inc. - Common Stock

Heat Biologics' Subsidiary Outlines Development of New Commercial/Biodefense Biomanufacturing Facility
Via Benzinga
66 Biggest Movers From Yesterday
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement. Forge Global... 
Via Benzinga
Heat Biologics' Merger Partner Elusys Finalizes HHS Contract For Its Anthrax Treatment
Elusys Therapeutics Inc, the merger partner for Heat Biologics Inc (NASDAQ: HTBX), has  
Via Benzinga
Heat Biologics Is Starting To Run Away From Support Toward Resistance
Heat Biologics Inc. (NASDAQ:HTBX) shares traded ... 
Via Benzinga
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
Heat Biologics Inc (NASDAQ: HTBX) announced promising preclinical data regarding PTX-35. The data has been accepted for publication in the American Journal of... 
Via Benzinga
Heat Biologics To Bolster Presence In Biodefense Space With Elusys Acquisition
Heat Biologics Inc (NASDAQ: HTBX) will acquire Elusys Therapeutics, a commercial-stage biodefense company and the manufacturer of Anthim (obiltoxaximab)... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.8... 
Via Benzinga
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company... 
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Tyme Technologies (NASDAQ:TYME) s... 
Via Benzinga
Heat Biologics Surges On Patent Filing
Heat Biologics Inc. (NASDAQ:HTBX) shares traded higher Thu... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
66 Biggest Movers From Yesterday
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
Heat Biologics' Lead Candidate Shows Overall Survival Benefit In Lung Cancer Study
Heat Biologics Inc (NASDAQ: HTBX) has reported interim data from the Phase 1/2 trial evaluating its lead product, HS-110, in combination with ... 
Via Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Advaxis (NASDAQ:ADXS) shares increased by 27.34% to $0.62 during Wednesday's pre-market session. The company's market cap stands at $85.2 million. Lixte... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Auris Medical Holding (NASDAQ:EARS) stock increased by 21.8% to $5.25 during Monday's pre-market session. The company's market cap stands at $67.5 million... 
Via Benzinga
Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021
DURHAM, NC / ACCESSWIRE / April 12, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,... 
From Heat Biologics, Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.